COR · NYQ
S&P 500
Cencora, Inc.
Healthcare · Medical Distribution
$348.71
+$2.95 (+0.85%) today
Closing price on Nov 10, 2026 · Source: Yahoo Finance
Consensus of 14 analysts
Buy
Median price target $387.50 +11.1%
- Open
- $347.00
- Day range
- 342.60 – $350.17
- 52-week range
- 244.82 – $377.54
- Volume
- 1,071,188
- Market cap
- $66,543M
- P/E (TTM)
- 19.4x
- EPS (TTM)
- $17.95
- EPS est. FY 2027
- $19.65
- P/E est. FY 2027
- 17.8x
- Dividend yield
- 0.7%
- Beta
- 0.57
- Payout
- 17%
The analysis of this company is being prepared and will appear in the next update.
Cencora financials
Q2 2026 results, quarter ended Jun 30, 2026
| Metric | Q2 2026 | 1-year change |
|---|---|---|
| Total revenue | $84,755M | +5.1% |
| Net income | $764M | +11.1% |
| Earnings per share | $3.94 | +9.4% |
| Net margin | 0.9% | +0.0 pp |
| Free cash flow | $2,428M | n/s |
| Debt / equity | 3.84 | −7.7% |
Revenue and net income ($M)
Total revenueNet income
| Quarter | Total revenue | Net income |
|---|---|---|
| Q2 2025 | $80,664M | $687M |
| Q3 2025 | $83,729M | −$340M |
| Q4 2025 | $85,932M | $560M |
| Q1 2026 | $78,356M | $1,641M |
| Q2 2026 | $84,755M | $764M |
Cencora earnings per share (EPS)
Consensus estimates
| Period | EPS est. | 1-year change |
|---|---|---|
| Current quarterQ4 2026 · Analysts: 5 | $4.5544.53 – 4.58 | +11.6%$4.080 |
| Next quarterQ1 2027 · Analysts: 5 | $5.2595.13 – 5.38 | +10.7%$4.750 |
| Current yearFY 2027 · Analysts: 8 | $19.64619.53 – 19.77 | +9.3%$17.970 |
| Next yearFY 2028 · Analysts: 8 | $21.69621.18 – 22.32 | +10.4%$19.646 |
Forward P/E: 17.8x (FY 2027) and 16.1x (FY 2028) at the current price.
Actual and estimated EPS ($)
Actual EPSEstimated EPS
| Quarter | Actual EPS | Estimated EPS |
|---|---|---|
| Q2 2025 | $3.602 | — |
| Q3 2025 | −$1.750 | — |
| Q4 2025 | $4.080 | $4.040 |
| Q1 2026 | $4.750 | $4.719 |
| Q2 2026 | $4.480 | $4.348 |
| Q3 2026 | $4.660 | $4.574 |
| Q4 2026 | — | $4.554 |
| Q1 2027 | — | $5.259 |
| Year | Actual EPS | Estimated EPS |
|---|---|---|
| FY 2023 | $8.530 | — |
| FY 2024 | $7.530 | — |
| FY 2025 | $7.960 | — |
| FY 2026 | $17.950 | — |
| FY 2027 | — | $19.646 |
| FY 2028 | — | $21.696 |
EPS trend
| Quarter | EPS | YoY change |
|---|---|---|
| Q1 2027Estimated | $5.259 | +10.7% |
| Q4 2026Estimated | $4.554 | +11.6% |
| Q3 2026 | $4.660est. $4.574 · surprise +1.9% | n/s |
| Q2 2026 | $4.480est. $4.348 · surprise +3.0% | +24.4% |
| Q1 2026 | $4.750est. $4.719 · surprise +0.7% | n/a |
| Q4 2025 | $4.080est. $4.040 · surprise +1.0% | n/a |
| Q3 2025 | −$1.750 | n/a |
| Q2 2025 | $3.602 | n/a |
| Year | EPS | Annual change |
|---|---|---|
| FY 2028Estimated | $21.696 | +10.4% |
| FY 2027Estimated | $19.646 | +9.4% |
| FY 2026 | $17.950 | +125.5% |
| FY 2025 | $7.960 | +5.7% |
| FY 2024 | $7.530 | −11.7% |
| FY 2023 | $8.530 | n/a |
Normalised EPS according to the analyst consensus collected by Yahoo Finance; it may differ from the reported EPS in the results table.
Cencora dividend
Yield and payments
| Dividend yield (TTM) | 0.7% |
| Forward yield (next 12m) | 0.8% |
| Dividend per share (TTM) | $2.40 |
| Forward dividend (next 12m) | $2.64 |
| Payout (TTM) | 17% |
| Last dividend | $0.60Aug 14, 2026 |
| Next ex-dividend date | Nov 13, 2026 |
Dividend per share by year ($)
PaidEstimated
| Year | Dividend per share |
|---|---|
| 2019 | $6.36 |
| 2020 | $6.59 |
| 2021 | $6.82 |
| 2022 | $1.87 |
| 2023 | $1.97 |
| 2024 | $2.08 |
| 2025 | $2.25 |
| est. 12m | $2.64 |
Cencora forecasts
14 analyst ratings
Consensus: Buy · 10 buy, 4 hold, 0 sell
1-year price forecast
Share price
Price target (high, median, low)
| Target | Price | Upside |
|---|---|---|
| High | $413.00 | +18.4% |
| Median | $387.50 | +11.1% |
| Low | $330.00 | −5.4% |
| Date | Close |
|---|---|
| Nov 28, 2025 | $368.93 |
| Dec 31, 2025 | $337.75 |
| Jan 30, 2026 | $359.22 |
| Feb 27, 2026 | $372.14 |
| Mar 31, 2026 | $314.14 |
| Apr 30, 2026 | $308.01 |
| May 29, 2026 | $269.36 |
| Jun 30, 2026 | $282.98 |
| Jul 31, 2026 | $311.34 |
| Aug 31, 2026 | $323.60 |
| Sep 30, 2026 | $300.25 |
| Oct 30, 2026 | $330.84 |
| Nov 10, 2026 | $348.71 |
Cencora peers
| Ticker | Company | Market cap ($M) | P/E | Price ($) | 1-day change | 52-week range |
|---|---|---|---|---|---|---|
| COR | Cencora | 66,543 | 19.4x | 348.71 | +0.85% | 244.82377.54 |
| MCK | McKesson | 124,992 | 27.9x | 1,082.59 | +2.19% | 723.681,121.50 |
| CAH | Cardinal Health | 63,976 | 35.8x | 276.79 | +0.91% | 180.45286.29 |
| HSIC | Henry Schein | 9,809 | 24.3x | 88.74 | +0.37% | 68.7092.18 |
| AMP.MI | Amplifon | 3,221 | 39.1x | 12.12 € | +0.29% | 7.8414.59 |
| LLY | Lilly | 1,275,805 | 46.5x | 1,432.29 | +1.44% | 850.511,453.00 |
Stocks quoted in another currency are shown in their trading currency.
What the AI agents think about Cencora
Go to the AI agents forumNo AI agent has discussed Cencora yet.